These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7538430)

  • 21. Analysis of pulmonary and systemic vascular responses to platelet-activating factor in the cat.
    Bellan JA; Minkes RK; Hood JS; McMahon TJ; Higuera TR; Nossaman BD; McNamara DB; Kadowitz PJ
    Am J Physiol; 1992 Jul; 263(1 Pt 2):H234-43. PubMed ID: 1379004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-activating factor increases lung vascular permeability to protein.
    Burhop KE; Garcia JG; Selig WM; Lo SK; van der Zee H; Kaplan JE; Malik AB
    J Appl Physiol (1985); 1986 Dec; 61(6):2210-7. PubMed ID: 3804927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quinolines attenuate PAF-induced pulmonary pressor responses and edema formation.
    Falk S; Göggel R; Heydasch U; Brasch F; Müller KM; Wendel A; Uhlig S
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1734-42. PubMed ID: 10556149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence against a role for platelet-activating factor in hypoxic pulmonary vasoconstriction in the rat.
    McCormack DG; Barnes PJ; Evans TW
    Clin Sci (Lond); 1989 Oct; 77(4):439-43. PubMed ID: 2805602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity.
    Resta TC; Walker BR; Eichinger MR; Doyle MP
    J Appl Physiol (1985); 2002 Oct; 93(4):1327-36. PubMed ID: 12235032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.
    Ono S; Westcott JY; Voelkel NF
    J Appl Physiol (1985); 1992 Sep; 73(3):1084-92. PubMed ID: 1400021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of thromboxane in mediating the intrarenal vasoconstriction induced by unmodified stroma free hemoglobin in the isolated perfused rat kidney.
    Lieberthal W; LaRaia J; Valeri CR
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):663-7. PubMed ID: 1391492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of platelet-activating factor in the modulation of vascular tone in the isolated perfused rabbit kidney.
    Cailleaux S; Lopes-Martins RA; Aimbire F; Cordeiro RS; Tibiriçá E
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):505-11. PubMed ID: 10431763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-activating factor is a key mediator of pulmonary vasoconstriction and bronchoconstriction after antigen challenge in the perfused sensitized rabbit lung.
    Shouji K; Enzan K; Mitsuhata H; Yoshioka N
    Shock; 1998 Jun; 9(6):412-5. PubMed ID: 9645492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-activating factor mediates trinitrobenzene induced colitis.
    Longo WE; Polities G; Vernava AM; Deshpande Y; Niehoff M; Chandel B; Kulkarni A; Kaminski DL
    Prostaglandins Leukot Essent Fatty Acids; 1994 Dec; 51(6):419-24. PubMed ID: 7708808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of circulating blood components and thromboxane in anaphylactic vasoconstriction in isolated canine lungs.
    Miyahara T; Shibamoto T; Wang HG; Koyama S
    J Appl Physiol (1985); 1997 Nov; 83(5):1508-16. PubMed ID: 9375313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
    Pretolani M; Lefort J; Malanchère E; Vargaftig BB
    Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-activating factor potentiates protamine-induced lung edema. Role of eicosanoids.
    Chen CR; Voelkel NF; Chang SW
    Am J Respir Crit Care Med; 1994 Jan; 149(1):34-40. PubMed ID: 8111595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-activating factor induces selective pulmonary arterial hyperreactivity in isolated perfused rabbit lungs.
    Ohar JA; Waller KS; Dahms TE
    Am Rev Respir Dis; 1993 Jul; 148(1):158-63. PubMed ID: 8317792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological responses to liposome-encapsulated hemoglobin (LEH) are improved by a PAF antagonist.
    Rabinovici R; Rudolph AS; Yue TL; Feuerstein G
    Circ Shock; 1990 Aug; 31(4):431-45. PubMed ID: 2397568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086.
    Chand N; Pillar J; Nolan K; Diamantis W; Sofia RD
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):155-8. PubMed ID: 1691522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the PAF antagonist WEB 2086 on PAF-induced physiologic alterations and on IgE anaphylaxis in the rabbit.
    Lohman I; Halonen M
    Am Rev Respir Dis; 1990 Aug; 142(2):390-7. PubMed ID: 2382903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of antigen- and ischemia-induced effects by the platelet-activating factor antagonist WEB-2086 in isolated sensitized rat hearts.
    Vleeming W; Wemer J; Porsius AJ
    J Cardiovasc Pharmacol; 1992; 20(5):790-9. PubMed ID: 1280743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor antagonists increase vascular reactivity in perfused rat lungs.
    Haynes J; Chang SW; Morris KG; Voelkel NF
    J Appl Physiol (1985); 1988 Nov; 65(5):1921-8. PubMed ID: 3209541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.